JULIENNE CAPRIA: Open Payments
NPI 1205332277 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 42 payments from 9 companies in 2025. Trend: 2023 $94 · 2024 $106 · 2025 $688
Food & beverage: $688
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $146 |
| E.R. Squibb & Sons, L.L.C. | 17 | $144 |
| Teva Pharmaceuticals USA, Inc. | 6 | $105 |
| ABBVIE INC. | 5 | $105 |
| Alkermes, Inc. | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $10 |
Products named: COBENFY, FANAPT, VRAYLAR, ARISTADA, UZEDY, CAPLYTA, AUSTEDO XR, HETLIOZ.
Industry payments across NY — which companies pay providers there.
